We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CVKD market cap is 7.21M. The company's latest EPS is USD -0.5220 and P/E is -0.86.
| Quarter End | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -973k | -4.2M | -1.03M | -1.14M |
| Net Income | -1.03M | -5.17M | -1M | -1.04M |
| Year End 31 December 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 |
| Operating Income | -2.7M | -7.63M |
| Net Income | -6.71M | -8.36M |
| Quarter End | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | |||
| Total Assets | 545k | 4.48M | 3.56M | 9.31M |
| Total Liabilities | 1.73M | 417k | 383k | 566k |
| Total Equity | -1.18M | 4.07M | 3.18M | 8.75M |
| Year End 31 December 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 778k | 8.52M |
| Total Liabilities | 6.33M | 827k |
| Total Equity | -5.55M | 7.69M |
| Market Cap | 7.21M |
| Price to Earnings Ratio | -0.86 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0.86 |
| Price to Book Ratio | 0.94 |
| Dividend Yield | - |
| Shares Outstanding | 16.01M |
| Average Volume (1 week) | 85.71k |
| Average Volume (1 Month) | 492.58k |
| 52 Week Change | -66.16% |
| 52 Week High | 3.14 |
| 52 Week Low | 0.36 |
| Spread (Intraday) | 0.04 (7.92%) |
| Company Name | Cadrenal Therapeutics Inc |
| Address |
651 n broad st suite 201 middletown, delaware 19709 |
| Website | https://www.cadrenal.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
